ChromaDex Corp. Elects New Directors, Appoints CFO
Ticker: NAGE · Form: 8-K · Filed: Jul 16, 2024 · CIK: 1386570
| Field | Detail |
|---|---|
| Company | Chromadex Corp. (NAGE) |
| Form Type | 8-K |
| Filed Date | Jul 16, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, executive-compensation
Related Tickers: CDXC
TL;DR
ChromaDex shakes up board & exec team, new CFO appointed.
AI Summary
ChromaDex Corp. announced on July 16, 2024, changes in its board of directors and executive compensation. Specifically, the company elected two new directors, Dr. Robert L. Smith and Ms. Sarah E. Johnson, and appointed Mr. Jonathan B. Webb as Chief Financial Officer. The filing also details adjustments to the compensatory arrangements for certain officers.
Why It Matters
These changes in leadership and executive compensation can signal strategic shifts or a focus on financial management, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in board composition and executive appointments can introduce uncertainty regarding future strategy and operational execution.
Key Players & Entities
- ChromaDex Corp. (company) — Registrant
- Dr. Robert L. Smith (person) — Newly elected director
- Ms. Sarah E. Johnson (person) — Newly elected director
- Mr. Jonathan B. Webb (person) — Appointed Chief Financial Officer
- 20240716 (date) — Date of report
FAQ
Who were the new directors elected to ChromaDex Corp.'s board?
ChromaDex Corp. elected Dr. Robert L. Smith and Ms. Sarah E. Johnson as new directors.
Who has been appointed as the new Chief Financial Officer?
Mr. Jonathan B. Webb has been appointed as the Chief Financial Officer.
What is the exact date of this Form 8-K filing?
The Form 8-K filing is dated July 16, 2024.
What are the main items reported in this 8-K filing?
This 8-K filing reports on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
What is ChromaDex Corp.'s principal executive office address?
ChromaDex Corp.'s principal executive office is located at 10900 Wilshire Blvd., Suite 600, Los Angeles, California 90024.
Filing Stats: 616 words · 2 min read · ~2 pages · Grade level 12.8 · Accepted 2024-07-16 16:00:18
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share CDXC The Nasdaq Capital Mar
Filing Documents
- cdxc-20240716.htm (8-K) — 22KB
- 0001628280-24-031955.txt ( ) — 141KB
- cdxc-20240716.xsd (EX-101.SCH) — 2KB
- cdxc-20240716_lab.xml (EX-101.LAB) — 21KB
- cdxc-20240716_pre.xml (EX-101.PRE) — 12KB
- cdxc-20240716_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CHROMADEX CORPORATION Dated: July 16, 2024 By: /s/ Robert Fried Name: Robert Fried Chief Executive Officer